News
12h
Interesting Engineering on MSNFluorescent drug gives surgeons visual upgrade with real-time nerve mappingIn the operating room, surgeons typically use high-powered microscopes fitted with specialized filters to detect the ...
The Food and Drug Administration (FDA) has approved an updated label for Amyvid (florbetapir F 18 injection) to support Alzheimer disease diagnosis in patients.
20h
Medical Device Network on MSNFDA grants 510(k) clearance for Philips’ deep learning reconstruction softwareThe US Food and Drug Administration (FDA) has granted 510 (k) clearance for Philips’ SmartSpeed Precise deep learning ...
Scientists from Duke University have created a tool that uses a single brain scan to estimate how quickly your body and mind ...
Pinpointing who will and won’t get Alzheimer’s disease is tricky for doctors, but new research suggests it may soon get ...
A new tool developed by researchers can estimate how fast someone is aging by analyzing a single MRI brain scan, predicting ...
Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...
Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work equally well for everyone. By mapping patients’ brain signals before and ...
A new study suggests that regular users of psychedelics may process self-related thoughts differently at both psychological ...
Vizamyl is now additionally indicated for use in a selection of patients who are indicated for amyloid beta-directed therapy as described in the prescribing information.
Simon Fraser University researchers are using a new approach to brain imaging that could improve how drugs are prescribed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results